CASI Pharmaceuticals (CASIF) Divestments (2022)

CASI Pharmaceuticals (CASIF) reported Divestments of $2.5 million for Q4 2022.

CASI Pharmaceuticals (CASIF) Divestments (2022) Analysis & Trends

CASI Pharmaceuticals has reported Divestments for 1 years, with the latest figure at $2.5 million in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Alterity Therapeutics 860,679.92 Bn 860,679.89 Bn - -
2 Belite Bio 55,284.00 Bn 55,284.00 Bn - -
3 Quantum Biopharma 16,206.94 Bn 16,206.93 Bn - -
4 Legend Biotech 3,318.00 Bn 3,317.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,543.84 Bn 1,543.84 Bn - -
6 Evaxion A 1,449.11 Bn 1,449.09 Bn - -
7 Psyence Biomedical 216.99 Bn 216.98 Bn - -
8 Vertex Pharmaceuticals 115.22 Bn 107.97 Bn 2.59 Bn -
9 Abivax 90.58 Bn 90.58 Bn - -
10 CASI Pharmaceuticals - - 3.69 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2022 2.50 Mn